Jump Financial »

Tscan Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $63k 11k 5.85
2024-03-31 $82k 10k 7.94

More positions owned by Jump Financial

SPDR Dow Jones Industrial Average ETF Trust Etf (DIA)
Invesco QQQ Trust Series 1 Etf (QQQ)
POSCO Holdings Depositary Receipt (PKX)
Vanguard S&P 500 ETF Etf (VOO)
VanEck Semiconductor ETF Etf (SMH)
CME Group Common Stock (CME)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Tesla Common Stock (TSLA)
Intercontinental Exchange Common Stock (ICE)
Technology Select Sector SPDR Fund Etf (XLK)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
Eli Lilly & Co Common Stock (LLY)

View all positions for Jump Financial

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BlackRock
BlackRock
BVF
Baker Bros. Advisors
Vanguard Group
Propel Bio Management
Deer Management
Alphabet
Simplify Asset Management
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Stempoint Capital
DC Funds

View all funds holding Tscan Therapeutics